<- Go Home
Microbot Medical Inc.
Microbot Medical Inc. is a medical device company that focuses on transforming endovascular procedures through advanced robotic technology. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, endovascular, and neurovascular operations. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system; and Emory University, in connection with autonomous robotics in endovascular procedures. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts
Market Cap
$142.4M
Volume
2.7M
Cash and Equivalents
$6.7M
EBITDA
-$14.0M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
N/A
Profit Margin
N/A
52 Week High
$4.67
52 Week Low
$0.89
Dividend
N/A
Price / Book Value
1.78
Price / Earnings
-5.39
Price / Tangible Book Value
1.78
Enterprise Value
$63.1M
Enterprise Value / EBITDA
-4.59
Operating Income
-$14.0M
Return on Equity
31.87%
Return on Assets
-20.17
Cash and Short Term Investments
$80.2M
Debt
$899.0K
Equity
$78.2M
Revenue
N/A
Unlevered FCF
-$6.0M
Sector
Health Care Equipment and Supplies
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium